Comera Life Sciences Holdings Inc (CMRA)
Comera Life Sciences Holdings Inc. is a biotechnology company listed on OTC Markets under the ticker CMRA. The company is in a preclinical stage and is focused on developing a portfolio of proprietary therapeutic candidates built around its internal formulation platform. Its SQore platform is intended to convert intravenous biologics into subcutaneous versions. Comera Life Sciences Holdings was founded in 2014 and is headquartered in Woburn, Massachusetts.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CMRA
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.03 K
|
—
|
—
|
—
|
—
|
—
|
—
|